Mangrove Partners’s New Frontier Health Corporation Ordinary Shares NFH Stock Holding History

Mangrove Partners’s Portfolio NFH Stock Details NFH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-293,910	Closed	-$3.37M	–	678
2021 Q4	$3.37M	Buy	+293,910	New	+$3.31M	0.2%	175
2019 Q3	–	Sell	-250,000	Closed	-$2.52M	–	109
2019 Q2	$2.52M	Hold	250,000	–	–	0.28%	51
2019 Q1	$2.48M	Hold	250,000	–	–	0.33%	46
2018 Q4	$2.45M	Hold	250,000	–	–	0.33%	43
2018 Q3	$2.4M	Buy	+250,000	New	+$2.4M	0.15%	32

Other funds holding NFH

Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

MCP

Maso Capital Partners Hong Kong $60.9M AUM 0.32% 1-Year Est. Return

Mangrove Partners's NFH Position: Q1 2022 in Review

Mangrove Partners sold out of New Frontier Health Corporation Ordinary Shares (NFH) in Q1 2022, closing a stake of 293,910 shares — an estimated $3.37M sold.

Mangrove Partners first reported a position in NFH in Q3 2018 and held it in 5 quarters. The position peaked at $3.37M in Q4 2021. 2 funds tracked by Wall St. Rank hold NFH as of Q1 2022.

Mangrove Partners reported no remaining New Frontier Health Corporation Ordinary Shares position as of Q1 2022 after selling out during the quarter.
Mangrove Partners sold 293,910 New Frontier Health Corporation Ordinary Shares shares in Q1 2022, an estimated $3.37M.
Mangrove Partners first reported a position in New Frontier Health Corporation Ordinary Shares in Q3 2018 and held it in 5 quarters.
Mangrove Partners's New Frontier Health Corporation Ordinary Shares position peaked at $3.37M in Q4 2021.
2 funds tracked by Wall St. Rank held New Frontier Health Corporation Ordinary Shares as of Q1 2022.

Based on Mangrove Partners's 13F filing for Q1 2022, filed 16 May 2022.